A new HeartMate 3™ LVAD Patient Education Handbook for ADULTS is Now Available!
ACTION is proud to release our newest patient education material for ADULT patients with the HeartMate 3™ LVAD.
ACTION is proud to release our newest patient education material for ADULT patients with the HeartMate 3™ LVAD.
Placement of a ventricular assist device (VAD) improves outcomes in children with advanced heart failure, but adverse events remain important consequences. Preoperative mechanical ventilation (MV) increases mortality, but it is unknown what impact prolonged postoperative MV has.
Abstract We report the largest pediatric multicenter experience with Impella pump use and peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. Utilizing the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) collaborative …
Ventricular assist devices (VADs) have been increasingly implanted in pediatric patients. Paracorporeal VADs are generally chosen when intracorporeal continuous (IC) devices are too large. Superiority between IC and paracorporeal pulsatile (PP) devices remains unclear in smaller pediatric patients. Our study analyzes outcomes of IC and PP VADs in pediatric patients who could be considered for either of these options.
Happy New Year! We hope you enjoyed the Holiday Season and are energized for a new year! We wrapped 2023 with the launch of several exciting projects, such as the HeartMate 3TM Discharge Bundle and Heart Healthy Video Series, we continued access to the Berlin Heart Active Driver under the extended trial, and we published new ACTION research. Looking ahead this year we have been meeting individually with all ACTION sites to ensure successful engagement in ACTION and highlight membership benefits for each center. We are excited to expand quality improvement, education, research, and best practice initiatives across the network, as well as engage with Global centers and increase advocacy efforts in the pediatric heart failure space. Reach out with any new ideas for the year ahead. Thank you for your continued efforts!
CINCINNATI — April 17, 2024 / PRNewswire/ Breaking new ground in youth health promotion, acclaimed actor, singer, and musician Julian Lerner partners with ACTION, the Advanced Cardiac Therapies Improving Outcomes Network, to …
Check out our educational handout on An Introduction to Myocarditis. Included is information about: What is Myocarditis? How is it diagnosed? What are the causes and the symptoms? Treatment options …
Ventricular assist device (VAD) use for failed stage II palliation (S2P) is increasing with limited data on outcomes.
The HeartWare ventricular assist device (HVAD) was discontinued in July 2021. The study aims to describe the impact the discontinuation the HVAD had on pediatric ventricular assist device (VAD) utilization and outcomes.